← All stocks

SAB Biotherapeutics, Inc.

SABS No buying or selling
CIK 0001833214 #3457 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

3 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Moin Andrew
Director
2,198,457
$1.93M
+379.5%
Sessa Capital (Master), L.P. entity
Director
2,198,457
$1.93M
+379.5%
Kropotova Alexandra
CHIEF MEDICAL OFFICER
41,853
$36.83K
−27.2%

No percentages here. This company's share count has moved by a factor of 9.9 over the window, from 9,229,274 to 90,986,368 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Sessa Capital (Master), L.P.
29 Sep 2025
Director
Exercised, kept
1,740,000
$1.75
$3.05M
Moin Andrew
29 Sep 2025
Director
Exercised, kept indirect
1,740,000
$1.75
$3.05M

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,483,437
History held since 14 Jan 2021